President Yoweri Museveni today launches the first clinical trial of UBV-01N, a natural product anticipated to have antiviral (kill viruses), anti-inflammatory (reduces over reaction of the body to infections) and immunological (directs the immune system in the right direction) ability. The Presidential Scientific Initiative On Epidemics (PRESIDE) in a Press Statement says the clinical trial will validate the content, standardization and replication of the product after which it will be rolled out for industrial production and wide spread use. The product has already gone through multiple quality assurance steps and got all necessary certifications and approval for use in human…
This Is Premium Content. Subscribe And Save On Unlimited Access With Our Best Offers!
